An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease.
about
An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
An open-label, non-comparative ...... tro-esophageal reflux disease.
@ast
An open-label, non-comparative ...... tro-esophageal reflux disease.
@en
type
label
An open-label, non-comparative ...... tro-esophageal reflux disease.
@ast
An open-label, non-comparative ...... tro-esophageal reflux disease.
@en
prefLabel
An open-label, non-comparative ...... tro-esophageal reflux disease.
@ast
An open-label, non-comparative ...... tro-esophageal reflux disease.
@en
P2093
P2860
P1476
An open-label, non-comparative ...... tro-esophageal reflux disease.
@en
P2093
Alexandra Papadokostopoulou
Angeliki Mestoussi
Athanasios Arhimandritis
Dimitrios Tzourmakliotis
Emmanuel Paraskevas
Irini Zouboulis-Vafiadis
Maria Hatzikyriakou
Nikolaos Katsilabros
Vassilios Vasdekis
P2860
P304
P577
2014-01-01T00:00:00Z